×

What are you searching for?




Business

4 Min read

SAMSUNG BIOLOGICS BUILDING NEW PLANT FOR FUTURE GROWTH ENGINES

Published On 19 Mar 2021 05:45 AM


SHARE THIS ARTICLE  


Highlights –

  • Samsung Biologics building new plant for future growth engines.
  • The company will produce and manufacture biopharmaceutical products for major pharmaceutical firms.
  • The new upcoming plant is said to be worth $1.4 billion.
  • In 2020, the company recorded sales of around 1.16 trillion won for the first time.

South Korean pharmaceutical firm Sams....


Tags : SAMSUNG BIOLOGICS, BIOPHARMACEUTICAL PRODUCTS, CDMO BUSINESS, SAMSUNG BIOLOGICS CEO, JOHN RIM,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)